Professional Documents
Culture Documents
1093/mutage/geq085
Advance Access Publication 27 October 2010
COMMENTARY
Reflections on the development of micronucleus assays
John A. Heddle1, Michael Fenech2, Makoto Hayashi3 and was interesting. McLeish (4) showed that some MN could
James T. MacGregor4,* decondense and reform an acentric fragment when the cell
1
Department of Biology, York University, Toronto, Ontario M3J 1P3, Canada, again entered mitosis and that MN with nucleoli could
replicate. The first use of MN as an index of chromosomal
details. Our two original publications were delayed by my move methods was satisfactory because one could not be certain
to York University in 1971. I thought that the report (17) would whether the labelled cells had actually completed nuclear
be published quickly (rather than in 1972) and that our MN division or had, in fact, completed only one division.
work would be referred to specifically but neither happened. After considerable frustration, the ‘eureka’ moment occurred
Our work was designed to establish that MN originated from very early one summer morning in 1984 when it occurred to
chromosome aberrations and that the method was more efficient me that the optimal point at which to identify once-divided
than chromosomal analysis, besides being easier, which we did. cells is the short-lived binucleated stage in telophase. I
The final evidence was the DNA content of MN (18). wondered how one could block cytokinesis so that the cell,
In any case, I was planning to move on and suggested to having completed nuclear division, would no longer be able to
Paul Countryman, my first MSc student, that an assay could be complete cellular division. A quick search that morning of the
developed in human lymphocytes that would be robust, term ‘cytokinesis’ in Lehninger’s ‘Principles of Biochemistry’
sensitive and quick, which he showed to be true (19). One of undergraduate text book disclosed a brief sentence mentioning
the complications that arose early was the definition of an MN. cytochalasins as inhibitors of cytokinesis by blocking poly-
4
Development of MN assays
radiation exposure was then verified for the first time in nucleoplasmic bridges and nuclear buds indicates that these
cancer patients undergoing radiotherapy (25). Using kinet- biomarkers of genomic instability are mechanistically related
ochore antibodies, it was demonstrated that the great major- to one another. They could be explained by the breakage-
ity of MN induced by ionising radiation were kinetochore fusion-bridge cycle model when the nutritional or exposure
negative while those induced by spindle poisons were ki- conditions generated double-strand breaks in DNA and led to
netochore positive, as one would expect given that radiation the formation of dicentric chromosomes (37–40,42).
causes chromosome breakage leading to acentric chromo- The possibility of scoring nucleoplasmic bridges in the
some fragments (26,27). CBMN cytome assay is of particular importance given that it is
During my postdoctoral training at the MRC Cell Mutation a potentially reliable assay for dicentric chromosome formation
Unit in Sussex, UK, in 1988, I visited Jim Parry’s laboratory in and therefore relevant to radiation biodosimetry (40,42). It also
Swansea (Wales). Jim had started coordinating an aneuploidy allows a possible functional assay for telomere dysfunction
research program funded by the European Union that even- when combined with telomere probes (36), given that telomere
tually identified the in vitro CBMN assay (in combination with end fusions lead to dicentric chromosome formation and
5
J. A. Heddle et al.
interact with RNA and DNA. When unfixed peripheral blood dose levels, is no longer available (as MS/Ae) commercially.
erythrocytes are stained with acridine orange, a reticulum is This group also evaluated the route of administration. Of 17
formed in reticulocytes (immature erythrocytes) and fluoresces chemicals, only 2 chemicals gave contradictory results between
red and MN yellow/green. Only a tiny amount of peripheral intraperitoneal (i.p.) injection and oral gavage administration
blood is necessary for this method, so one can take a sample for [per os (p.o.)]: potassium chromate (VI) gave a positive response
the MN assay repeatedly from the same animal. It also allows by the i.p. but not by the p.o. route and benzene p.o. gave
classification of reticulocytes into different age categories, positive results but i.p. gave only a marginal response (53).
which can give more mechanistic and expression kinetics The peripheral blood of rat was also evaluated with 40
information. This method was evaluated and validated by the chemicals although spleens of rat as well as human eliminate
international collaboration organized by the Collaborative micronucleated erythrocytes efficiently from peripheral blood
Study Group on the Micronucleus Test (CSGMT), which is (54). The concordance between bone marrow and peripheral
a study group in the Mammalian Mutagen Study (MMS) blood in rats was 92% and that between rat and mouse
group, which is a sub-organization belonging to the Japanese erythrocytes was 88%; thus, it was concluded that the rat
Environmental Mutagen Society (49). Because it is not peripheral blood can be used as well as mouse.
necessary to kill animals to evaluate the micronucleated CSGMT/MMS engaged the study on the evaluation of the
reticulocyte (MNRET) frequency, repeat sampling and evalu- rodent MN assay by a 28-day repeat treatment protocol (55).
ation of spontaneous MNRET from the same animals Fifteen model mutagens were tested in rats mainly by p.o.
throughout the entire life span is possible (50). Using this administration daily for 28 days and were evaluated in bone
method, it has been shown that both sexes of the BDF1 strain marrow cells and peripheral blood. Thirteen chemicals were
and females of the A/J strain showed a statistically significant positive within the estimated dose range of a general
increase in mean spontaneous MNRET frequency in their last toxicology test, suggesting the possibility of integration of
month of the life, suggesting the possibility of strain-specific the MN end point into general toxicology tests. These data
age-dependent chromosomal instability. SAMP6/Tan, an were used in the revision of the mutagenicity guideline of
accelerated senescence-prone strain, showed the same ten- International Conference on Harmonisation of Technical
dency. The other strains studied, ddY, CD-1, B6C3F1, SAMR1 Requirements for Registration of Pharmaceuticals for Human
and MS/Ae, did not show age-related differences. Use. The group also studied .100 chemicals that were
To standardize the methodology of the erythrocyte MN assay, evaluated by the International Agency for Research on Cancer
extensive collaborative studies have been conducted by the as human carcinogens (Group 1), probable human carcinogens
MMS group, of which I was a part. The group organised (Group 2A) and possible human carcinogens (Group 2B),
extensive collaborative studies on the factors that might influence using the rodent MN assay, and concluded that if information
results of the assay. The first objective was the evaluation of about the structure of the chemical was taken into account, the
differences between male and female mice. They showed that positive rates of the rodent MN assay were 90%, 65% and 60%
there was no essential qualitative difference but there were for Group 1, Group 2A and Group 2B, respectively (56).
several quantitative differences. The differences, however, There are several advantages of the erythrocyte MN assay
diminished when dose levels were adjusted based on the area using rodent haematopoietic cells in comparison with those of
of body surface rather than being based on the body weight (51). metaphase analysis in evaluation of clastogenicity/aneugenicity
In the second collaborative study, mouse strain differences of chemicals. One of the important advantages was the simple
were evaluated (52). All four strains used gave positive results end point, namely the small nucleus-like inclusion in the
with all six model positive control chemicals. Unfortunately, erythrocyte from which the main nucleus has been expelled.
the mutagen-sensitive strain, which seemed superior at high Therefore, the MN is the only DNA-containing structure in the
6
Development of MN assays
erythrocyte. This characteristic made it feasible for us and development of simple and effective flow cytometric scoring
others to develop automated scoring of MN frequencies by techniques, applicable to small blood samples from the species
image analysis (57,58) and flow cytometry (59–64). of most scientific interest, was eventually successful and is
discussed in the article by Dertinger et al. in this special issue
of Mutagenesis.
Regulatory applications and human health and safety
Initially, it was known that many species, including the rat
studies (J.T.M.)
(74), beagle dog (75) and human (76), actively remove
I began my scientific career in the early 1970s, a time at which micronucleated cells from the peripheral circulation, and it
the recent recognition that chemical exposures could induce was believed that this would preclude the use of peripheral
inheritable genetic alterations responsible for human disease, blood samples in these important species. In the human, initial
including cancer (2,65), converged with the introduction of two studies showed that microscopic scoring of MNRET and red
new simple laboratory assays that permitted the detection and blood cells in the peripheral blood of splenectomised
monitoring of important genetic changes. These assays were individuals could be used as an index of damage in bone
7
J. A. Heddle et al.
has enabled the field of genetic toxicology to move from its 15. Salamone, M. F. and Heddle, J. A. (1983) The bone marrow micronucleus
previous reliance on hazard screening assays toward a more assay: rationale for a revised protocol. In Hollaender, A. (ed), Chemical
Mutagens, Vo1. 8. Plenum, New York, pp. 111–149.
quantitative evaluation of in vivo risks associated with specific 16. Heddle, J. A., Hite, M., Kirkhart, B., Mavournin, K., MacGregor, J. T.,
exposures to potentially genotoxic agents (99–101). This Newell, G. W. and Salamone, M. F. (1983) The induction of micronuclei
integrated assessment of genetic and other health risks, together as a measure of genotoxicity. A report of the U.S. Environmental Agency
with appropriate human studies, promises a major improve- Gene—Tox Program. Mutat. Res., 123, 61–118.
ment in our approaches to assessing those factors that affect 17. Nichols, W. W., Moorhead, P., Brewen, J. G. et al. (1972) Chromosome
methodologies in mutagen testing. Tox. Appl. Pharm., 22, 269–275.
human health and safety. 18. Heddle, J. A. and Carrano, A. V. (1977) The DNA content of micronuclei
induced in mouse bone marrow by X-irradiation: evidence that micro-
nuclei arise from acentric chromosomal fragments. Mutat. Res., 44, 63–69.
Concluding comment and acknowledgements 19. Countryman, P. I. and Heddle, J. A. (1976) The production of micronuclei
from chromosome aberrations in irradiated cultures of human lympho-
We hope that this historical perspective will be of interest to cytes. Mutat. Res., 41, 321–332.
those in the field of genetic toxicology research and that it will
8
Development of MN assays
induced by reactive oxygen species and activated human neutrophils. 59. Huetter, K. and Stöhr, M. (1982) Rapid detection of mutagen induced
Mutagenesis, 15, 261–269. micronucleated erythrocytes by flow cytometry. Histochemistry, 75,
39. Crott, J. W., Mashiyama, S. T., Ames, B. N. and Fenech, M. (2001) The 353–362.
effect of folic acid deficiency and MTHFR C677T polymorphism on 60. Tometsko, A. M. (1991) An automated peripheral blood micronucleus
chromosome damage in human lymphocytes in vitro. Cancer Epidemiol. assay using flow cytometry. Environ. Mol. Mutagen., 17 (Suppl. 19), 74.
Biomarkers Prev., 10, 1089–1096. 61. Hayashi, M., Norppa, H., Sofuni, T. and Ishidate, M., Jr (1992) Flow
40. Thomas, P., Umegaki, K. and Fenech, M. (2003) Nucleoplasmic bridges cytometric micronucleus test with mouse peripheral erythrocytes.
are a sensitive measure of chromosome rearrangement in the cytokinesis- Mutagenesis, 7, 257–264.
block micronucleus assay. Mutagenesis, 18, 187–194. 62. Dertinger, S. D., Torous, D. K. and Tometsko, K. R. (1996) Simple and
41. Kimura, M., Umegaki, K., Higuchi, M., Thomas, P. and Fenech, M. reliable enumeration of micronucleated reticulocytes with a single-laser
(2004) Methylenetetrahydrofolate reductase C677T polymorphism, folic flow cytometer. Mutat. Res., 371, 283–292.
acid and riboflavin are important determinants of genome stability in 63. Dertinger, S. D., Torous, D. K., Hall, N. E., Tometsko, C. R. and
cultured human lymphocytes. J. Nutr., 134, 48–56. Gasiewicz, T. A. (2000) Malaria-infected erythrocytes serve as biological
42. Fenech, M. (2010) The lymphocyte cytokinesis-block micronucleus standards to ensure reliable and consistent scoring of micronucleated
cytome assay and its application in radiation biodosimetry. Health Phys., erythrocytes by flow cytometry. Mutat. Res., 464, 195–200.
9
J. A. Heddle et al.
81. MacGregor, J. T., Bishop, M. E., McNamee, J. P. et al. (2006) Flow 100. Thybaud, V., Aardema, M., Clements, J. et al. (2007) Strategy for
cytometric analysis of micronuclei in peripheral blood reticulocytes: II. An genotoxicity testing: hazard identification and risk assessment in relation
efficient method of monitoring chromosomal damage in the rat. Toxicol. to in vitro testing. Mutat. Res., 627, 41–58.
Sci., 94, 92–107. 101. Thybaud, V., MacGregor, J. T., Müller, L. et al. (2010) Strategies in case
82. Dertinger, S. D., Bishop, M. E., McNamee, J. P. et al. (2008) Flow of positive in vivo results in genotoxicity testing (IWGT Expert Working
cytometric analysis of micronuclei in peripheral blood reticulocytes: I. Group Report). Mutat. Res., (in press).
Intra- and interlaboratory comparison with microscopic scoring. Toxicol. 102. Parvinen, M., Lähdetie, J. and Parvinen, L. M. (1984) Toxic and
Sci., 94, 83–91. mutagenic influences on spermatogenesis. Arch. Toxicol. Suppl., 7,
83. Hayashi, M., MacGregor, J. T., Gatehouse, D. G. et al. (2007) In vivo 128–139.
erythrocyte micronucleus assay: III. Validation and regulatory acceptance
of automated scoring and the use of rat peripheral blood reticulocytes,
with discussion of non-hematopoietic target cells and a single dose-level
limit test (IWGT Expert Working Group Report). Mutat. Res., 627, 10–30.
84. Harper, S. B., Dertinger, S. D., Bishop, M. E., Lynch, A. M., Lorenzo, M.,
Saylor, M. and MacGregor, J. T. (2007) Flow cytometric analysis of
10